1315 Capital raises $300 mln for second fund
Philadelphia-based 1315 Capital has raised $300 million for its fund, 1315 Capital II, according to a regulatory filing. The firm invests in pharmaceutical, medical technology, and healthcare service companies, according to its website. It is led by Adele Oliva, Michael Koby, and Brian Schwenk. The fund closed at its hard cap of $300 million, exceeding its $250 million target, according to a press release. The filing lists 57 investors.
15 February 2018•1 min read
